EQHQ
Login
EQHQ
Search your stocks
Login
Command Palette
Search for a command to run...
Explore
Watchlists
Chat
Portfolio
Share
Profile
KILITCH
Overview
Shareholding
Peers
Financials
Ratios
Concall
Feed
Documents
KILITCH
Kilitch Drugs (India) Ltd.
360
(-1.06%)
1W: +0.66%
1M: -16.39%
1Y: -4.64%
Ratios
Cash Conversion Cycle
Latest:
-7.6 days
Return on Equity
Latest:
8.4%
Return on Capital Employed
Latest:
13.3%
Dupont Analysis
Analysis Summary
Metric
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
ROE
0.71%
3.09%
4.73%
5.86%
8.43%
PAT margin
9.46%
7.48%
6.45%
5.36%
1.58%
Asset Turnover
0.38x
0.40x
0.56x
0.66x
0.68x
Leverage
1.20x
1.41x
1.56x
1.51x
1.41x
Efficiency Ratios
Analysis Summary
Metric
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Inventory Days
35.1
24.3
13.7
9.2
7.1
Receivable Days
120.7
103.0
102.8
125.1
138.9
Payable Days
71.8
297.2
269.2
204.4
153.6
Cash Conversion Cycle
84.0
-169.9
-152.7
-70.1
-7.6
Return Ratios
Analysis Summary
Metric
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
ROE
0.71%
3.09%
4.73%
5.86%
8.43%
ROCE
1.95%
4.40%
7.26%
10.26%
13.30%
ROA
0.59%
2.19%
3.03%
3.89%
5.97%
Explore
Watchlists
Chat
Portfolio